Form 4 for NYAX Nayax Ltd.
Accepted 2026-08-27 07:54:35 ET · period of report 2026-08-26 · accession 0001976408-26-000776 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-27 07:54 | 2026-08-26 | NYAX | Nechmad Yair | CEO, COB, Co Founder, Dir | M - OptEx | $33.71 | +235.6K | 7.33M | +3% | +$7.94M |
| DM | 2026-08-27 07:54 | 2026-08-26 | NYAX | Nechmad Yair | CEO, COB, Co Founder, Dir | M - OptEx | $0.00 | -235.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-26 | M | A | 75,000 | $33.71 | 7,168,442 | D | — | — | (F3) The shares were acquired upon the exercise of stock options (F4) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. |
| 2 | Common | Ordinary Shares | 2026-08-26 | M | A | 75,000 | $33.71 | 7,243,442 | D | — | — | (F3) The shares were acquired upon the exercise of stock options (F4) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. |
| 3 | Common | Ordinary Shares | 2026-08-26 | M | A | 70,000 | $33.71 | 7,313,442 | D | — | — | (F3) The shares were acquired upon the exercise of stock options (F4) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. |
| 4 | Common | Ordinary Shares | 2026-08-26 | M | A | 15,605 | $33.71 | 7,329,047 | D | — | — | (F3) The shares were acquired upon the exercise of stock options (F4) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-08-26 | M | D | 75,000 | $0.00 | 0 | D | $33.71 · 2022-03-08 to 2027-03-08 | 75,000 Ordinary Shares | (F1) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. (F2) The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I . |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-08-26 | M | D | 75,000 | $0.00 | 0 | D | $33.71 · 2025-03-04 to 2030-03-04 | 75,000 Ordinary Shares | (F1) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. (F2) The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I . |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-08-26 | M | D | 70,000 | $0.00 | 0 | D | $33.71 · 2022-03-08 to 2027-03-08 | 70,000 Ordinary Shares | (F1) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. (F2) The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I . |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-08-26 | M | D | 15,605 | $0.00 | 0 | D | $33.71 · 2025-03-04 to 2030-03-04 | 15,605 Ordinary Shares | (F1) The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. (F2) The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I . |